BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xi Y, Xu PF. Therapeutic potentials of fasudil in liver fibrosis. World J Gastroenterol 2021; 27(45): 7859-7861 [PMID: 34963748 DOI: 10.3748/wjg.v27.i45.7859]
URL: https://www.wjgnet.com/1948-5182/full/v27/i45/7859.htm
Number Citing Articles
1
Yara A. Zaky, Mai W. Rashad, Marwa A. Zaater, Ahmed M. El Kerdawy. Discovery of dual rho-associated protein kinase 1 (ROCK1)/apoptosis signal–regulating kinase 1 (ASK1) inhibitors as a novel approach for non-alcoholic steatohepatitis (NASH) treatmentBMC Chemistry 2024; 18(1) doi: 10.1186/s13065-023-01081-3
2
Esam M. Aboubakr, Ahmed R. N. Ibrahim, Fares E. M. Ali, Ahmed A. E. Mourad, Adel M. Ahmad, Amal Hofni. Fasudil Ameliorates Methotrexate-Induced Hepatotoxicity by Modulation of Redox-Sensitive SignalsPharmaceuticals 2022; 15(11): 1436 doi: 10.3390/ph15111436
3
Hendrik Vercammen, Martin Ondra, Jana Kotulova, Edgar Cardenas De La Hoz, Charissa Witters, Katerina Jecmenova, Maxim Le Compte, Christophe Deben, Sorcha Ní Dhubhghaill, Carina Koppen, Marián Hajdúch, Bert Van den Bogerd. “Keep on ROCKIn”: Repurposed ROCK inhibitors to boost corneal endothelial regenerationBiomedicine & Pharmacotherapy 2024; 174: 116435 doi: 10.1016/j.biopha.2024.116435